Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Hendrix

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2014
HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV preventionDeborah Donnell, Jared M Baeten, Namandjé N Bumpus, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2020
Brief Report: Associations Between Self-Reported Substance Use Behaviors and PrEP Acceptance and Adherence Among Black MSM in the HPTN 073 StudyChukwuemeka N Okafor, Christopher Hucks-Ortiz, Lisa B Hightow-Weidman, et al.
AIDS and Behavior|May 29, 2025
Assessing the Acceptability of a Tenofovir-Based Rectal Microbicide Douche among Young Men who Have Sex with Men: Results from ATN-DREAM (ATN 163)José A Bauermeister, Willey Lin, Jessica Webster, et al.
Plos One|October 29, 2014
A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarateKuo-Hsiung Yang, Craig Hendrix, Namandje Bumpus, et al.
Statistics in Medicine|January 26, 2022
Combining information to estimate adherence in studies of pre-exposure prophylaxis for HIV prevention: Application to HPTN 067James P Hughes, Brian D Williamson, Chloe Krakauer, et al.
AIDS and Behavior|May 28, 2017
Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United StatesElizabeth T Montgomery, Lisa M Noguchi, James Y Dai, et al.
AIDS and Behavior|November 17, 2016
Optimizing Pre-Exposure Antiretroviral Prophylaxis Adherence in Men Who Have Sex with Men: Results of a Pilot Randomized Controlled Trial of "Life-Steps for PrEP"Kenneth H Mayer, Steven A Safren, Steven A Elsesser, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV InfectionPeng Xiao, Sanjeev Gumber, Mark A Marzinke, et al.
Sexually Transmitted Diseases|January 15, 2021
Determinants of HIV Preexposure Prophylaxis Adherence Among Female Sex Workers in a Demonstration Study in Cotonou, Benin: A Study of Behavioral and Demographic FactorsAminata Mboup, Souleymane Diabaté, Luc Béhanzin, et al.
AIDS (London, England)|February 14, 2006
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected womenKenneth H Mayer, Lisa A Maslankowski, Fang Gai, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2014
HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV preventionDeborah Donnell, Jared M Baeten, Namandjé N Bumpus, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2020
Brief Report: Associations Between Self-Reported Substance Use Behaviors and PrEP Acceptance and Adherence Among Black MSM in the HPTN 073 StudyChukwuemeka N Okafor, Christopher Hucks-Ortiz, Lisa B Hightow-Weidman, et al.
AIDS and Behavior|May 29, 2025
Assessing the Acceptability of a Tenofovir-Based Rectal Microbicide Douche among Young Men who Have Sex with Men: Results from ATN-DREAM (ATN 163)José A Bauermeister, Willey Lin, Jessica Webster, et al.
Plos One|October 29, 2014
A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarateKuo-Hsiung Yang, Craig Hendrix, Namandje Bumpus, et al.
Statistics in Medicine|January 26, 2022
Combining information to estimate adherence in studies of pre-exposure prophylaxis for HIV prevention: Application to HPTN 067James P Hughes, Brian D Williamson, Chloe Krakauer, et al.
AIDS and Behavior|May 28, 2017
Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United StatesElizabeth T Montgomery, Lisa M Noguchi, James Y Dai, et al.
AIDS and Behavior|November 17, 2016
Optimizing Pre-Exposure Antiretroviral Prophylaxis Adherence in Men Who Have Sex with Men: Results of a Pilot Randomized Controlled Trial of "Life-Steps for PrEP"Kenneth H Mayer, Steven A Safren, Steven A Elsesser, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV InfectionPeng Xiao, Sanjeev Gumber, Mark A Marzinke, et al.
Sexually Transmitted Diseases|January 15, 2021
Determinants of HIV Preexposure Prophylaxis Adherence Among Female Sex Workers in a Demonstration Study in Cotonou, Benin: A Study of Behavioral and Demographic FactorsAminata Mboup, Souleymane Diabaté, Luc Béhanzin, et al.
AIDS (London, England)|February 14, 2006
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected womenKenneth H Mayer, Lisa A Maslankowski, Fang Gai, et al.
Pageof 4